DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie